For oncology patients, the target range is noted as 150–200 nmol/L (≈ 60–80 ng/mL). The general “ordinary wellness” range is cited as 100–150 nmol/L.
For oncology patients, the target range is noted as 150–200 nmol/L (≈ 60–80 ng/mL). The general “ordinary wellness” range is cited as 100–150 nmol/L.